EDUCATIONAL WEBINAR: Evidence-Based Strategy in the Prevention of Complications due to Retained Blood

An Educational Webinar with Presenters: Marc Gillinov, MD, Marc Gerdisch, MD, and Alyson Mehringer, RN discussing the basic principles of Chest Tube Management, the results of a 1 year quality improvement study and the operational perspective from the ICU Nursing Staff.

News

FDA Expands Label Indication for PleuraFlow to Reduce Retained Blood

Anaheim, CA – June 03, 2015— ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that the United States Food & Drug Administration (FDA) has granted expanded Indications for Use of the company’s patented PleuraFlow® Active Clearance Technology® System. The PleuraFlow System is a patented medical device that prevents chest drains from occluding with clot, which can lead to retained blood around the heart and…

Read more

Report: Increased Stays in ICU Related to Retained Blood Syndrome After Cardiac Surgery

Anaheim, CA – May 11, 2015— ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that cardiac critical care investigators presented data last week at the 62nd annual German Anesthesia Congress (DAC 2015) in Düsseldorf, Germany about outcomes in patients who develop Retained Blood Syndrome (RBS) from incomplete blood evacuation after cardiac surgery. Cardiac Anesthesia specialists from Charité University Hospital Berlin’s Department of Anesthesiology and Intensive…

Read more

High Readmission Rates for Patients with Retained Blood Syndrome after Cardiac Surgery

Seattle, WA–April 27, 2015—A panel of distinguished heart surgeons from leading cardiac centers shared their experiences and strategies to optimize patient recovery after cardiothoracic surgery at a panel discussion in Seattle yesterday. Of emphasis was the ongoing challenge of high complication rates for patients struggling with postoperative acute, sub-acute and chronic complications after surgery due to inadequate drainage, known as Retained Blood Syndrome (RBS).

Read more

Study Demonstrates Concern for Retained Blood Syndrome after Heart Surgery

Anaheim, CA – March 25, 2015—Cardiac anesthesia investigators from Germany presented data this week at the International Anesthesia Research Society’s (IARS) 2015 Annual Meeting and International Science Symposium in Honolulu, HI. Critical care specialists from Charité – Universitätsmedizin Berlin’s Department of Anesthesiology and Intensive Care Medicine presented clinical data from 6,909 patients. Results from the data revealed that more than 16% of the patients studied required surgical reinterventions…

Read more

ClearFlow’s PleuraFlow System Exhibited at Association of Physician Assistants in Cardiovascular Surgery Meeting

Anaheim, CA – March 2, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, is currently exhibiting its innovative PleuraFlow® Active Clearance Technology® System at the 34th annual Association of Physician Assistants in Cardiovascular Surgery (APACVS) meeting in Las Vegas. PleuraFlow will also be displayed at the Maquet Medical Systems USA booth through March 4th. Maquet is the exclusive distributor of ClearFlow’s PleuraFlow System in the USA.

Read more

ClearFlow Exhibits PleuraFlow System at Society of Thoracic Surgeons Annual Meeting

Groundbreaking Device Designed to Prevent Retained Blood Syndrome Draws Crowds in San Diego   Anaheim, CA – January 26, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, is currently exhibiting its innovative PleuraFlow® Active Clearance Technology® System at the Society of Thoracic Surgeons (STS) 51st  Annual Meeting in San Diego. PleuraFlow will continue to be displayed at ClearFlow’s booth (#636) at STS today and tomorrow.

Read more

Maquet Medical Systems USA Announces Exclusive US Distribution Agreement with ClearFlow for PleuraFlow® Active Clearance Technology® System

WAYNE, N.J., Jan. 23, 2015 /PRNewswire/ — Maquet Medical Systems USA announced today an exclusive US distribution agreement with ClearFlow, Inc. for its innovative PleuraFlow® Active Clearance Technology® (ACT™) System. The PleuraFlow System enables caregivers to actively keep chest drainage tubes clear of clot in the early hours after heart surgery. Maquet’s sales representatives in the United States will begin selling PleuraFlow ACT during the first quarter of…

Read more